Skip to main content
. 2023 Apr 3;2023(4):CD007920. doi: 10.1002/14651858.CD007920.pub4
Study Reason for exclusion
Bai 2021 Wrong study design
ChiCTR‐IPR‐15006695 Wrong intervention
ChiCTR‐OPN‐16008147 Wrong study design
Dorrans 2020 Wrong study design
Elwehidy 2019 Wrong intervention
EUCTR2007‐000585‐21‐IE Study not completed or confirmed
EUCTR2008‐005464‐14‐DE Wrong study design
Gou 2020 Wrong study design
IRCT2016042527595N1 Wrong patient population
Jiang 2019 Wrong study design
JPRN‐UMIN000000895 Wrong study design
JPRN‐UMIN000001136 Wrong study design
JPRN‐UMIN000003854 Wrong study design
JPRN‐UMIN000013974 Wrong study design
Liu 2020 Wrong comparator
Muhsen 2019 Wrong patient population
NCT02914626 Study not completed or confirmed
NCT04970251 Wrong study design
RBR‐9wkw73j Wrong patient population
Song 2019 Wrong study design
Sun 2019 Wrong study design
TCTR20160826002 Wrong intervention
Wu 2020 Wrong comparator
Yang 2020 Wrong comparator
Yuryevich 2019 Wrong study design
Zarei 2021 Wrong patient population
Zhao 2020 Wrong comparator

anti‐VEGF: anti‐vascular endothelial growth factor
IOP: intraocular pressure
IVB: intravitreal bevacizumab
mg: milligram
MMC: mitomycin C
NVG: neovascular glaucoma
PRP: panretinal photocoagulation
RCT: randomized controlled trial